Literature DB >> 11342610

Protein kinase C-theta mediates a selective T cell survival signal via phosphorylation of BAD.

M Villalba1, P Bushway, A Altman.   

Abstract

Protein kinase C (PKC)-activating phorbol esters protect T cells from Fas-induced apoptosis. However, the mechanism of this protective effect and the identity of the relevant PKC isoform(s) are poorly understood. Here, we show that PKCtheta plays a selective and important role in this protection. Fas triggering led to a selective caspase-3-dependent cleavage of the enzyme and proteasome-mediated degradation and inactivation of its catalytic fragment. These events preceded the onset of apoptosis. Pharmacological inhibition of PKCtheta promoted Fas-mediated apoptosis in three different types of T cells. Conversely, constitutively active PKCtheta (and, to a lesser degree, PKCepsilon) selectively protected T cells from Fas-induced apoptosis. We provide evidence that the distant Bcl-2 family member, BAD, is a PKCtheta substrate, is phosphorylated by TCR stimulation, and can mediate at least in part the anti-apoptotic effect of PKCtheta.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342610     DOI: 10.4049/jimmunol.166.10.5955

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Ligation of CD8 leads to apoptosis of thymocytes that have not undergone positive selection.

Authors:  Kristie M Grebe; Raedun L Clarke; Terry A Potter
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-01       Impact factor: 11.205

2.  Protection from rapamycin-induced apoptosis by insulin-like growth factor-I is partially dependent on protein kinase C signaling.

Authors:  Kuntebommanahalli N Thimmaiah; John B Easton; Peter J Houghton
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

Review 3.  The yin and yang of protein kinase C-theta (PKCθ): a novel drug target for selective immunosuppression.

Authors:  Elizabeth Yan Zhang; Kok-Fai Kong; Amnon Altman
Journal:  Adv Pharmacol       Date:  2013

Review 4.  The emerging role of protein kinase Cθ in cytoskeletal signaling.

Authors:  Izabela Michalczyk; Aleksander F Sikorski; Leszek Kotula; Richard P Junghans; Patrycja M Dubielecka
Journal:  J Leukoc Biol       Date:  2012-11-27       Impact factor: 4.962

5.  FLIP protects against hypoxia/reoxygenation-induced endothelial cell apoptosis by inhibiting Bax activation.

Authors:  Xue Wang; Yong Wang; Jinglan Zhang; Hong Pyo Kim; Stefan W Ryter; Augustine M K Choi
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

6.  Biochemical and genetic evidence for a SAP-PKC-theta interaction contributing to IL-4 regulation.

Authors:  Jennifer L Cannons; Julie Z Wu; Julio Gomez-Rodriguez; Jinyi Zhang; Baoxia Dong; Yin Liu; Stephen Shaw; Katherine A Siminovitch; Pamela L Schwartzberg
Journal:  J Immunol       Date:  2010-07-28       Impact factor: 5.422

7.  An alternative mode of CD43 signal transduction activates pro-survival pathways of T lymphocytes.

Authors:  Maria Elena Bravo-Adame; Rosario Vera-Estrella; Bronwyn J Barkla; Cecilia Martínez-Campos; Angel Flores-Alcantar; Jose Pablo Ocelotl-Oviedo; Gustavo Pedraza-Alva; Yvonne Rosenstein
Journal:  Immunology       Date:  2016-10-12       Impact factor: 7.397

Review 8.  Protein kinase C theta (PKCtheta): a key player in T cell life and death.

Authors:  Keitaro Hayashi; Amnon Altman
Journal:  Pharmacol Res       Date:  2007-05-01       Impact factor: 7.658

9.  Intervention of PKC-θ as an immunosuppressive regimen.

Authors:  Zuoming Sun
Journal:  Front Immunol       Date:  2012-08-02       Impact factor: 7.561

10.  Protein Kinase C-θ (PKC-θ) in Natural Killer Cell Function and Anti-Tumor Immunity.

Authors:  Alberto Anel; Juan I Aguiló; Elena Catalán; Johan Garaude; Moeez G Rathore; Julián Pardo; Martín Villalba
Journal:  Front Immunol       Date:  2012-07-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.